Amarin Corp Plc (AMRN)

[Biobillionair]

Why is Amarin going to update on operations next Tuesday? Seems like a waste of time unless they have a real update. Has the media released the blockade on Vascepa?

Amarin Corporation plc (ADR) (NASDAQ:AMRN) shares increased 4.02% and was closed at $2.07. AMRN EPS was $1.33%. AMRN year to date (YTD) performance is 111.29%. Company Name AMRN weekly volatility is calculated as 4.68% and price to cash ratio as 3.18. AMRN showed a weekly performance of 6.15%. Amarin Corporation plc (ADR) (NASDAQ:AMRN)on November 24, 2015 a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced that John F. Thero, Amarin’s President and Chief Executive Officer, is scheduled to present a general company update at the Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, December 1, 2015, at 12:30 p.m. ET.

Can Investors Bet on AMRN after this News update? Find out in this Research Report
http://investorwired.com/movers-of-most-recent-trading-session-grubhub-inc-grub-amarin-corporation-plc-adr-amrn-arch-coal-inc-aci/1775153

More:
http://www.wsnewspublishers.com/active-stocks-in-focus-amarin-corporation-plc-adr-nasdaqamrn-goodyear-tire-rubber-co-nasdaqgt-hsbc-holdings-plc-adr-nysehsbc/1541873/

More:
http://www.stocksnewswire.com/business-finance/traders-recap-deere-company-nysede-amarin-corporation-nasdaqamrn-the-goodyear-tire-rubber-company-nasdaqgt/abcd/13145/